Cleared Traditional

K082363 - COOK SYDNEY IVF BLASTOCYST VITRIFICATIO...

K082363 is an FDA 510(k) clearance for COOK SYDNEY IVF BLASTOCYST VITRIFICATIO..., manufactured by William A. Cook Australia Pty. , Ltd.. The device is a Class 2 Obstetrics & Gynecology device with product code MQL cleared through the Traditional 510(k) pathway after a 254-day FDA review.

K082363 · William A. Cook Australia Pty. , Ltd. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2009
Decision
254d
Days
Class 2
Risk

K082363 is an FDA 510(k) clearance for the COOK SYDNEY IVF BLASTOCYST VITRIFICATION (K-SIBV-5000), WARMING (K-SIBW-5000).... Classified as Media, Reproductive (product code MQL), Class II - Special Controls.

Submitted by William A. Cook Australia Pty. , Ltd. (Eight Mile Plains, Qld, AU). The FDA issued a Cleared decision on April 29, 2009 after a review of 254 days - an extended review cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6180 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all William A. Cook Australia Pty. , Ltd. devices

FDA 510(k) Submission Details - K082363

510(k) Number K082363 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 18, 2008
Decision Date April 29, 2009
Days to Decision 254 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
94d slower than avg
Panel avg: 160d · This submission: 254d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQL Device Classification - Class 2, Special Controls

Product Code MQL Media, Reproductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6180
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MQL Media, Reproductive

All 168
Devices cleared under the same product code (MQL) and FDA review panel - the closest regulatory comparables to K082363.
GLOBAL DMSO BLASTOCYST VITRIFICATION KIT AND WARMING KIT
K092667 · Intl., Inc. · Jun 2010
LIFEGLOBAL PROTEIN SUPPLEMENT
K092578 · Intl., Inc. · Apr 2010
VIT KIT - FREEZE AND THAW
K093273 · Irvine Scientific Sales Co., Inc. · Mar 2010
LIFEGLOBAL HUMAN SERUM ALBUMIN LG HSA
K083509 · Intl., Inc. · Apr 2009
BLASTASSIST WITHOUT PHENOL RED, MODEL REF 1215, BLASTASSIST WITH PHENOL RED, MODEL REF 1216
K080172 · Medicult A/S · Dec 2008
RAPIDVIT AND RAPIDWARM CLEAVE
K080446 · Vitrolife Sweden AB · Nov 2008